Effects of leptin replacement on risk factors for cardiovascular disease in genetically leptin-deficient subjects.
Paz-Filho
G J
GJ
Center for Pharmacogenomics, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Andrews
D
D
Esposito
K
K
Erol
H K
HK
Delibasi
T
T
Wong
M-L
ML
Licinio
J
J
D000328:Adult; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000276:immunology*; D005260:Female; D006801:Humans; D018836:Inflammation Mediators / Q000097:blood; D020738:Leptin / Q000031:analogs & derivatives* / Q000172:deficiency* / Q000627:therapeutic use; D008297:Male; D009765:Obesity / Q000150:complications* / Q000188:drug therapy* / Q000276:immunology / Q000378:metabolism; D012307:Risk Factors
D018836:Inflammation Mediators; D020738:Leptin; C122136:recombinant methionyl human leptin